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BIG DATA ANALYTICS APPLIED TO HEALTHCARE
Xuejuan Zhang 1 and Boris Vishnevsky 2
Doctor of Management in Strategic Leadership
School of Continuing and Professional Studies
Thomas Jefferson University
Philadelphia, PA 19144
In this paper, we review the recent (primarily from 2018 - 2020) literature related to Big Data
Analytics (BDA). We also discuss ways of applying BDA in Healthcare. In Section 1, we discuss
the definition of Big Data Analytics and its characteristics. In section 2, we discuss the
healthcare ecosystem's main stakeholders and the data of each main stakeholder (i.e., healthcare
provider, healthcare payer, and patient/consumer). Section 3 discusses the challenges and
opportunities of leveraging Big Data Analytics by healthcare stakeholders.

1. Definition of Big Data Analytics and Its Characteristics
Several Big Data definitions have been suggested in the literature as efforts evolve to understand
this new field. In this review, we use the consensus definition proposed by the National Institute
of Standards and Technology (NIST, https://www.nist.gov/). NIST has been leading
collaboration between industry, academia, and government since 2013, and launched the NIST
Big Data Public Working Group (NBD-PWG).
NIST (2019) defines Big Data as a large amount of data in the networked, digitized, sensorladen, information-driven world. Moreover, the characteristics of Big Data that force new
architectures can be described in terms of "V"s as follows.
•
•
•
•

Volume denotes the size of the dataset
Velocity is the rate of the flow of data
Variety refers to the multitude of different repositories of data
Variability concerns the change in speed or structure

NIST (2019) uses these characteristics as fundamental drivers that define the overall design of a
Big Data system. This foundation supports several different data system architectures with
multiple analytics life cycles that enable the system’s outcomes, including performanceeffectiveness, function-appropriateness, and cost-efficiency.
In addition to the 4"V" BDA characteristics, the Big Data may carry additional features also
referred to as "V" attributes:
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•
•
•
•
•

Veracity is the accuracy, conformity of the data, or description for data quality issues
Validity is the appropriateness of the data for its intended use
Volatility is the tendency for data structures to change over time
Visualization is the usage of charts and graphs to visualize large amounts of complex data
as an effective way to convey the meaning of data
Value is the monetary value or business benefits achieved by an organization or
individual who acquires, analyzes, or distributes the data

BDA concerns the application of advanced analytic techniques to big data sets, which has led
some researchers to use the words big data and big data analytics interchangeably. The
development of digital technologies and advanced analytical tools, such as the Internet of Things
(IoT) or Networks of Things (NoT), Artificial Intelligence (A.I.), and Machine Learning (ML),
drive the growth of big data and big data analytics. Based on the purpose or the roles in the
BDA, new technologies may be categorized into three main groups: techniques for acquiring and
analyzing data, technologies for storing and sharing data, and technologies for data
communication (Table 1).
Table 1: Digital Technologies Related to Big Data Analytics
Main Purpose
Data Acquisition and Analysis
Data Storage / Data Sharing
Data Communication

Technologies
A.I., IoT/NoT
Blockchain; Cloud computing
Mobile devices with apps; social network (Facebook,
Twitter) / messengers (WhatsApp); Video and Image
platforms (YouTube, Instagram)

Internet of Things (IoT) commonly refers to a connected world in which every element or 'thing'
sends and receives information through sensors. NIST (2016) uses the term Network of Things
(NoT) as a synonym of IoT and argues that IoT is an instantiation of NoT, e.g., IoT has its
'things' tethered to the Internet. NIST (2016) provides an NoT model based on IoT-based
technologies' underlying and foundational science because the realization of IoT involves
sensing, computing, communication, and actuation. In the NoT model, NIST uses the term
primitive to represent smaller pieces from which larger blocks or systems can be built rather than
focus on a definition for what is or is not a ‘thing.’ The primitives of NoT are called the sensor,
aggregator; communication channel; external utility (e-Utility), and decision trigger.
Artificial Intelligence (A.I.) and A.I. technologies are the software and/or hardware systems that
can learn to solve complex problems and make predictions. A.I. systems can also undertake tasks
that require human-like sensings such as vision, speech, and touch, perception, cognition,
planning, learning, communication, or physical action (NIST, 2019b). Examples include A.I.
assistants (e.g., ChatBots), computer vision systems, unattended vehicle systems, and facial
recognition systems.
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Machine Learning (ML) refers to the components of A.I. systems that learn from data to perform
tasks that require human intelligence. The ML components of an A.I. system include the data,
model, and processes for training, testing, and validation (NIST, 2019c).
Blockchains are tamper-evident and tamper-resistant digital ledgers implemented in a distributed
fashion (i.e., without a central repository) and usually without a central authority such as a bank,
company or government (NIST, 2018). This technology became widely known in 2009 with the
launch of the Bitcoin network, the first of many modern cryptocurrencies.
Cloud computing is a model for enabling ubiquitous, convenient, on-demand network access to a
shared pool of virtualized and configurable computing resources (e.g., networks, servers, storage,
applications, and services). These cloud-based computing resources can be rapidly provisioned
and released with minimal management effort or service provider interaction (NIST, 2011).
2. The Healthcare Ecosystem and Major Stakeholders
Healthcare is a complex system consisting of interdependencies among many stakeholders often
with different interests that must be viewed as an ecosystem according to Woolf and Aron (20134). The primary stakeholder groups of a healthcare system include health professionals
(physicians and nurses), health facilities (clinics, hospitals, urgent care), financing institutions or
payers (insurance companies and other third-party payers), patients or consumers, and social
services. Health professionals can come from various health sectors including dentistry,
medicine, midwifery, nursing, psychology, physiotherapy, and many others (Dash, Shakyawar,
Sharma & Kaushik, 2019).
Of the characteristics of big data (4 Vs) to healthcare, variety could be a defining feature because
stakeholders of the healthcare ecosystem can generate a variety of data in different forms. Table
2 defines the main domains of data generated by healthcare providers, payers, patients, and
social services.
Table 2: Major Types of Data by Major Healthcare Stakeholder
Healthcare Stakeholder
Provider
Payer
Patient/Consumer
Social Service

Major Forms of Data
Electronic Healthcare Record
Electronic Medical Record/Insurance Record
Personal health record / user-generated health and healthrelated data
HHS, CMS, Medicare, APCDs generate, aggregate, and
curate large volumes of health care, social service, and
performance data.

Healthcare providers information related to the medical history of a patient including medical
diagnoses, medical imaging, pharmacy prescriptions, demographics, clinical narratives, and the
results of various laboratory tests. This test information is increasingly stored, managed, and
shared in a digital form known as Electronic Health Records (EHR). The adoption of EHRs was
3

slow at the beginning of the 21st century, but it has grown substantially after 2009. HER provides
several advantages to healthcare providers such as easy access to the entire medical history of a
patient, faster reporting of quality indicators, better continuity of care, reduction of medical
errors and greater efficiency related to electronic authorization and immediate insurance
approval due to less paperwork (Dash et al., 2019). Like HER, an electronic medical record
(EMR) stores the standard medical and clinical data gathered from patients.
The payers (insurance companies) commonly embrace big data more proactively than healthcare
providers. Indeed, digitalization has revolutionized the insurance operation. Big data analytics
has enormous influences on insurance value chains, including underwriting, rating, marketing,
product design, claim management, and customer services.
Besides the traditional EMR and insurance record, insurance companies are developing
capabilities to collect patient/consumer data at a more granular level. Over the past two decades,
insurance companies have increasingly begun to deploy data from third-party data sources. Two
new sources of data are relevant in the context of insurance (Geneva Association, 2018). The
first source concerns data automatically generated and stored with people's online behavior, such
as personal information shared via social media, individual online shopping behavior, and data
generated by personalized search and browsing activities. Personal data captured as part of the
online activities can reveal information about the habits and lifestyle, and complement data
traditionally used by insurance companies. The collection of such data is highly concentrated
with digital-first companies such as Alibaba, Alphabet (Google), Amazon, Facebook, and
Microsoft. The second new source of information is captured by sensors built into various
appliances and consumer goods, such as the wearable devices (i.e., Apple watch or fitness
trackers). These, combined with traditional data such as claims record, medical record, or family
member conditions, are increasingly used as inputs of automated predictive modeling and
decision-making processes leveraging A.I. or ML.
At the patient level, the development of technologies allows individuals to build personal health
records (PHR) in electronic format. More importantly, individuals can intentionally and
unintentionally generate more data that can be used to infer their health condition. Notable
examples include the data generated by fitness trackers and wearable devices and data created on
the social network containing personal socio-behavior information, such as individual financial
conditions, mental and physical status, diets, exercising records, and unique lifestyles.
Social services play an essential role in the healthcare ecosystem by extending and amplifying
health care services, e.g., Medicare and Medicaid. Social services also affect the so-called social
determinants of health (SDH). The development of BDA technologies enables the digitalization
of social services in combination with the delivery of healthcare. The integration of Social and
Health Care delivery services represents a significant challenge as well as an opportunity for
improving the value of health care while reducing its cost.
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3. Value Creation of Big Data Analytics for Healthcare Providers and Consumers
3.1 Healthcare Providers
Table 3 summarizes the significant opportunities and challenges of healthcare providers (see
Raghupathi & Raghupathi, 2016; Kruse et al., 2016; Mehta, & Pandit, 2018).
Table 3: Opportunities and challenges of BDA to Healthcare Providers
Opportunities
• Improve the quality of care
• Early detection of diseases
• Improve decision making
• Cost reduction
• Patient-centric care

Challenges
• Data structure
• Data security
• Data standardization
• Managerial issues
• Regulatory compliance

There are significant opportunities for BDA use by healthcare providers. One is to improve the
quality of care: the most certain benefit offered by BDA is to improve outcomes and improve the
health-related quality of life because BDA provides the healthcare provider with the ability to
predict outcomes better and help medication adherence at the patient's end.
A second is for early detection of diseases: BDA allows for the early detection of diseases, which
helps in clinical objectives related to achieving improved treatments and higher patient
outcomes. BDA can also help in the prevention and personalized disease management and
monitoring through tracking healthy behaviors and assisting patients in monitoring their
conditions.
BDA can also improve decision making: It enables the use of evidence-based medicine and helps
healthcare providers to make more informed decisions because BDA can help to optimize the
decision-making process by incorporated accurate and up-to-date information.
There can be significant cost reduction: savings can be realized through more cost-effective
treatments and monitoring to improve medication adherence. Moreover, the cost of dataintensive tasks can be reduced due to the decrease in computing and communication expenses.
Improved patient-centric care can be realized: BDA plays an essential role in changing the health
care sector from disease-centric care toward patient-centric care. It will allow patients to play an
active part in their care by providing them timely and appropriate information and through active
communication between patients and providers.
There are significant challenges of BDA when applied to healthcare providers. One concerns the
nature of the data structure: most data in healthcare are unstructured such as natural language; as
well, data such as HER are often fragmented and not well shared across different providers.
A second challenge is data security: there are considerable privacy concerns regarding the data
given existing legislation and regulation. Moreover, because of the sensitivity of healthcare data,
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concerns arise when specific data sets are made available as an opensource platform or shared
over the vendors on the value chains.
Data standardization is important because in the fragmented EHR platform, data are stored in
formats that are hard to be compatible with various applications and technologies.
Managerial issues include lack of digital-first mindset and required analytical skills that may
limit the adoption of BDA
Finally, regulatory compliance is a challenge: providers using a high volume of sensitive
healthcare data will have to comply with existing regulations specific to healthcare. Moreover,
providers will also need to pay attention to emerging rules for BDA and personal data.
The phrase digital-first healthcare organization means that organizations need to rethink how
business gets done and their value positions. It also refers to the revolutions in the product and
consumer experiences which informs the need to optimize existing business processes with new
digital methods. Deloitte (2018) suggests that healthcare providers should implement a use casedriven mentality and focus on delivering value. Healthcare providers should adopt a design
approach allowing rapid prototyping, testing, and piloting a variety of innovative business
processes with customers and partners.
Wang et al. (2018) propose a BDA-enabled transformation model from the practice-based
perspective. In this model, they argue that healthcare should develop and enhance capabilities
based on the three main architectural components of BDA: data aggregation, data analysis, and
data interpretation. Accordingly, healthcare providers shall develop three main BDA capabilities:
traceability (related to data aggregation), analytical solutions (related to data analysis), and
decision support capability (related to decision support capability). Using a case study approach
that examines the relevant practices of healthcare providers, they reported that healthcare
providers put a different level of priorities on those capability developments. The development of
analytical solutions is given the highest priority, whereas the traceability is developed with the
lowest priority.
3.2 Healthcare Payers
Table 4 summarizes the opportunities and challenges for healthcare payers (i.e., health insurance
companies) drawn from Eling and Lehmann (2018) and McKinsey (2019). Traditionally, health
insurance companies' business models are built on data such as historical medical claims data.
However, the advances of new technologies in BDA, A.I., and IoT have fundamentally changed
the role of data in the insurance business model and revolutionized the operations of insurance
companies. For instance, the significant areas of insurance value chains, such as underwriting,
product development, marketing, distribution, and claims management, are all affected by BDA
(Geneva Association, 2018; Eling & Lehmann, 2018).
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Table 4: Opportunities and challenges of BDA to Healthcare Payers
Opportunities
• Tailored insurance product
• Strengthen partnerships with providers
• Fully automated insurance process with
increased efficiencies
• Better engagement of customers.

Challenges
• Disruptions by technology start-ups and
technology titans
• Lack of skills
• Regulatory compliance.

Regarding challenges, healthcare payers face both internal and external challenges related to
BDA. Internal problems include the lack of skills for collecting, analyzing data, and making
informed business decisions accordingly. Moreover, healthcare insurers also face more stringent
regulatory requirements related to the enhanced use of personal data and the use of A.I. and ML
in the decision-making process. The primary external challenge faced by health insurance
companies is whether they will lose part or entire value chain to technology start-ups and
technology titans. Data are essential for the operation of health insurance companies, and
advantages of the technology include broad access to customers, respective data, and advanced
data analytical tools. BDA might take over part or even the entire insurance value chain and
issue their insurance product if the risk margin of being a producer were high enough (Eling &
Lehmann, 2018). Indeed, technology-driven firms such as Tencent and Alibaba have already
begun to start their joint ventures in property and life insurance business.
Similar to healthcare providers, healthcare payers need to respond to the influences of BDA and
digitalization. Eling and Lehmann (2018) suggest that insurance companies will have to invest in
IT and additional employee skills to integrate new technologies and innovative models within
their organizations. Moreover, insurance companies also need to carefully evaluate the benefits
and costs of running technological incubators and cooperating with technology-driven firms.
McKinsey (2019) suggests that there shall be three core business capabilities in the digital health
ecosystem: First are consumer components (e.g., personalized health services) provide digital
access points for consumers with tailored experiences focused on individual needs. Second are
provider components (e.g., integrated EHR) provide an integrated payer-provider data exchange
platform and distributed data management among payers and providers. Third are internal
components (automated digital core) provide technology foundations for the flexible data layer,
sophisticated analytics, and automation.
3.3 Patients
Deloitte (2018) summarizes the benefits of the patient by adopting BDA as patient-centric
healthcare that enables better health outcomes for consumers, provide simplified access to
healthcare products and solutions, reduce costs, and increase transparency (Table 5).
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Table 5: Opportunities and challenges of BDA to Patients
Opportunities
• Patient-centric healthcare
• Enhanced personalized medicine

Challenges
• Data privacy
• Potential Discriminations and insurability
of health risk

More relevant to the context of the U.S. health care system are the recent advancements of valuebased care models or programs. The Centers for Medicare & Medicaid Services (CMS) define
value-based programs as those that reward health care providers with incentive payments based
on the quality, rather than the quantity, of care provided to patients and that support a three-part
aim of better care for individuals; better health for populations; and lower cost. 3 CMS's valuebased programs include the End-Stage Renal Disease Quality Incentive Program, Hospital
Value-Based Purchasing (VBP) Program, Physician Value-based Modifier (PVBM) program,
and Hospital-Acquired Conditions Reduction Program. The goal of those programs is to link
provider performance of quality measures to provider payment. For instance, the Hospital VBP
program rewards acute care hospitals with incentive payments based on the quality of care
provided in the inpatient hospital setting. Hospitals are assessed on measures of outcome such as
mortality and complications, healthcare-associated infections, patient safety, patient experience,
process, and efficiency and cost reduction. The program will adjust a part of hospitals' Medicare
payments based on each measure of the hospitals' total performance. 4 These endeavors for
promoting value-based care create massive demand for tracking, storing, sharing, analyzing, and
validating the adopted quality measures. BDA will contribute significantly to these.
The potential challenges of BDA may include data privacy, issues related to discrimination, and
the insurability of health risk to the patient. Concerns over data privacy related to the enhanced
use of personal data by BDA are not new. Most Western countries provided protections
regarding the collection and use of data through existing public policies and regulations. For
instance, in the U.S., the Health Insurance Portability and Accountability of 1996 (HIPPA)
governs healthcare data. But the adoption and practice of big data analytics impose new
challenges because HIPPA does not regulate all the relevant health information. HIPPA does not
govern health information that is generated by entities not covered by HIPPA (e.g., life insurance
companies), or non-health information on which inferences about health are based, or usergenerated health information. To address this, the European Union introduced the General Data
Protection Regulation (GDPR) in 2018. GDPR strengthens the rights of individuals over their
data by requiring "unambiguous consent" to pass personal data and introduce the right to be
forgotten and data portability (Geneva Association, 2018). However, the lack of a unified
personal data protection standard could cause an increase in regulatory compliance costs.

https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/ValueBased-Programs. Accessed on May 1, 2020.
4
https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-BasedPrograms/HVBP/Hospital-Value-Based-Purchasing. Accessed on May 1, 2020.
3
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Moreover, the enhanced personal data use and automated decision-making process adopted by
health insurance companies may contribute to fairness and discrimination problems for patients.
Business models based on digital monitoring can either reward or penalize certain behaviors or
lifestyle choices that are labeled "good" or "bad" by the insurance companies. Such models may
be regarded as intrusive or "paternalistic" and as interring with an individual's autonomy in
decision making (Geneva Association, 2018). Individuals may have to make choices such as to
restrict their lifestyle options - eating less sugar and moving more often - because they cannot
pay health insurance for high-risk behaviors. Furthermore, decision-making by A.I. or ML may
not always be transparent and explainable. Sometimes it is difficult to determine which factor in
the predictive model plays a determining role. Regulators and policymakers around the world
have begun to respond to the regulatory and ethical challenges imposed by BDA.
One example is that Singapore introduced an A.I. governance framework in 2019 built on two
main guiding principles: (1) decisions made by or with the help of A.I. shall be transparent,
explainable, and fair; (2) A.I. systems shall be human-centric and safe. In the U.S., the National
Association of Insurance Commissioners (NAIC) has tasked its Casualty Actuarial and Statistical
Task Force (CASTF) to identify best practices for rating plans. These recommendations will
serve as guidance to state insurance departments (and insurers) in their review of complex
models that underly rating plans in personal property insurance, such as auto and homeowner
insurance. A similar approach and practice can also be applied to health-related insurance in the
future.
3.4 Social Services
Many health care services are delivered through various social services (e.g., Medicare in the
U.S.). As presented in Table 6, BDA offers opportunities for a new form of social services
characterized as "citizen-centered service delivery," which focuses on individual needs instead of
specific services provided by siloed government divisions (e.g., homeless, unemployed,
disabilities, and social needs). Modern information technologies can digitalize administrative
activities in one consolidated information system. These systems will leverage data collection
and decision-making components to provide a single source for citizen data, automated
eligibility determination, and electronic document management. BDA can help to improve
outcomes for citizens through cohesive delivery of social services while reducing the related
costs at the same time.
Table 6: Opportunities and challenges of BDA to Social Services
Opportunities
• Improved service delivery for citizens
• Enhanced personalized medicine
• Improvements in Public Health outcomes
• Transition to value-based health care delivery
• A more effective response to pandemics
• Reduction in fraud
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Challenges
• Digitization of the workforce
• Data integrity
• Funding models
• Government initiatives

As part of their continuous focus to transition to value-based care, the Department of Health and
Human Services (HHS), the Centers for Medicaid (CMS), and the Department of Justice (DOJ),
in partnership with the private sector, continue their efforts to eliminate wasteful spending, fraud,
and abuse in Medicare and Medicare programs. All-Payer Claims Databases (APCDs) aggregate
a broad range of health care data that is reported by the commercial sector along with Medicare
and Medicaid providers, as described by Khan (2016-Part 2) these APCD data offer a wide array
of information, including the utilization and cost related to the efficient delivery of quality health
care. The state-level APCD data sets can be utilized to improve the recovery rates and overall
effectiveness of the Health Care Fraud and Abuse Control Program, HCFAC (2013). BDA
applied to APCDs can also provide a unique insight in managing and reducing the impact of
global pandemics such as COVID-19.
While initially formed to coordinate and administer Medicare and Medicaid Programs as the
Health Care Financing Administration under HHS, CMS's scope has substantially expanded
since the creation of the agency more than 52 years ago. To reduce wasteful spending and fight
fraud and abuse, CMS and the DOJ worked together to enact the Health Care Fraud and Abuse
Control (HCFAC) Program, and to form the Healthcare Fraud Prevention Partnership (HFPP).
This partnership enables CMS to shift away from the "pay and chase" model to a more proactive
fraud prevention strategy, applying modern technology and BDA-based anti-fraud capabilities to
focus on provider screening and enrollment.
A study by Berwick and Hackbarth (2012) identified six categories of wasteful health care
spending: (1) failure of care delivery, (2) failure of care coordination, (3) overtreatment, (4)
administrative complexity, (5) pricing failures, and (6) fraud and abuse. APCD data aggregated
at the state level enables direct and indirect (derived via analytics) insight to improve outcomes
for these. According to the Bass and Berry (2018-2) review of HCFAC in 2017, a large
percentage of fraud and abuse cases typically fall under the False Claims Act as related to
"upcoding" and "unbundling" violations that without BDA could have only be captured as
overtreatment or pricing failures.
The combined wasteful and fraudulent spending for Medicare and Medicaid in 2011 can be
estimated between $133 billion (about 67% of total) and $262 billion (about 65% of total).
Based on DOJ HCFAC (2013) report for the years 2013 – 2017, the annual recovery was from
$3.1 billion to $6.7 billion range, representing only a 2-3% recovery rate. BDA could present a
substantial opportunity for further improvements. Leveraging and expanding the focus of
investigations and counter-fraud solutions to include state-level APCD data sets can improve the
recovery rates in several ways.
One is because the state-level APCDs aggregated health care data is self-reported by
Medicare/Medicaid as well as by commercially administered programs, the comparison of cost,
utilization, and quality between Medicare/Medicaid and commercial programs can be obtained.
This comparative analysis will quickly show any possible outliers, differences, or anomalies that
can be further studied by investigative units to determine the root causes.
Another is that the state-level APCD data are self-reported and represent state-wide health care
market-specific rates, cost, and utilization statistics that make it possible to identify the median
10

value for these attributes as well as potential outliers. Because APCD data are state- and marketspecific, counter-fraud systems over time can "learn" and maintain state- and market-specific
data points and interpret these data points within a national health care marketplace, access, and
utilization of state-specific APCDs data sets vary from state to state. Many U.S. states enable
free-of-charge access to APCD data for research and non-commercial purposes. In contrast, the
cost of APCD data for commercial use is determined individually based on the requester's role
and objectives. If the requester leverages APCD data to improve health care utilization and
value by reducing waste and abuse, this will lead to establishing a win-win outcome and the
relationship between the requester and the state-owner of the APCD data. Similar win-win
engagements with multiple states and APCDs would also contribute to and accelerate APCD
standardization activities.
Using state-level APCD data, counter-fraud solutions providers can substantially enhance the
effectiveness of their systems as well as the operational performance of special investigation
teams while improving APCD standardization, integration, and utilization at a national level.
The relationship between Public Health, Medical Care Systems, and Public Health outcomes are
quite complicated (Woolf & Aron, 2013-4). BDA can be leveraged to obtain more
comprehensive insight into function and interdependencies across these systems.
Several challenges exist for such a transformation of social and public health services.
First, it has been shown that providing proper training for the digitalization of workforce and
operation models with decades of history can be very challenging. Second, many people concern
about the data integrity issue related to a consolidated database that contains every bit of citizen
information. Third, political tensions can arise due to the budget/cost of building, such as an
integrated social services system and the question of the effectiveness of such a new system.
4. Conclusion
In this paper we reviewd the recent literature related to Big Data Analytics (BDA) and its
applications in Healthcare. We described how the development of technologies and analytical
tools have greatly reshaped the landscape of Healthcare. Looking into the future, we expect the
Healthcare sector will continue to witness the creative disruptions brought by the advancements
of BDA. As the Healthcare sector is best described as an ecosystem with many entangled
stakeholders, it is important to keep a holistic and dynamic view when examining the fastevolving technologies and business applications related to BDA. Moreover, researchers and
practitioners must be vigilant and cautious about new risks (e.g., cyber risk and regulatory
compliance issues) associated with BDA. We urge that prior to adopting new technologies and
new analytic tools that organizations consider comprehensive cost and benefit analysis and
scenario planning to address unintended outcomes.

11

References
Bass, F.M., Berry, F. & Sims, C. 2018. Health Care Fraud and Abuse Review 2017. Bass, Berry,
and Sims Health Care Task Force, 2018(2). Retrieved from: http://www.bassberry.com.
Berwick, D. M., & Hackbarth, A. D. 2012. The Six Categories of Wasteful Health Care
Spending. The Journal of the American Medical Association, 307 (14): 1515.
Dash, S., Shakyawar, S. K., Sharma, M. & Kaushik, S. 2019. Big Data in Healthcare:
Management, Analysis and Future Prospects. Journal of Big Data, 6, 54. Retrieved from:
https://doi.org/10.1186/s40537-019-0217-0.

Deloitte. 2018. The Digital Imperative: The Imperative for a Consumer-Centric, Digitally
Enabled Health Ecosystem. Retrieved from:
https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-lshc-thedigital-imperative.pdf

Eling, M., & Lehmann, M. 2018. The Impact of Digitalization on the Insurance Value Chain and
the Insurability of Risks. Geneva Papers on Risk and Insurance – Issues and Practice, 43:
359-396.
Galbraith, J. R. 2014. Organizational Design Challenges Resulting from Big Data. Journal of
Organization Design, 3(1): 2-13.
Geneva Association. 2018. Big Data and Insurance: Implications for Innovation, Competition,
and Privacy. Retrieved from: https://www.genevaassociation.org/research-topics/cyber-andinnovation-digitalization/big-data-and-insurance-implications-innovation

Grossman, R. L. &Siegel, K. P. 2014. Organizational Models for Big Data and Analytics.
Journal of Organization Design, 3(1): 20-25.
Grover, V., Chiang, R. H. L., Liang, T. & Zhang, D. 2018. Creating Strategic Business Value
from Big Data Analytics: A Research Framework. Journal of Management Information
Systems, 35(2): 388-423. Retrieved from: https://doi.org/10.1080/07421222.2018.1451951.
Groves, P., Kayyali, B., Knott, D. & Kuiken, S.V. 2013. The 'Big Data' Revolution in U.S.
Healthcare Accelerating Value and Innovation. McKinsay&Company. Retrieved from:
https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/the-big-datarevolution-in-us-health-care

HCFAC. 2013. Annual Report for Fiscal Year 2013.The Department of Health and Human
Services and The Department of Justice Health Care Fraud and Abuse Control Program,
Retrieved from: https://www.oig.hhs.gov/publications/docs/hcfac/FY2013-hcfac.pdf
Kahn J.. 2016. Written CMS Testimony 2016(Part 2). Washington (D.C.).
Retrieved from: https://www.ncvhs.hhs.gov/wp-content/uploads/2016/05/Panel-2-Jessica-KahnCMS-Written-20160June17.pdf

12

Kruse, C. S., Goswamy, R., Raval, Y. & S. Marawi, S. 2016. Challenges and Opportunities of
Big Data in Health Care: A Systematic Review. JMIR Med Inform 4(4), e38. Retrieved from:
http://medinform.jmir.org/2016/4/e38/.

McKinsey. 2019. Digital Health Ecosystems: A Payer Perspective. Retrieved from:
https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/digital-healthecosystems-a-payer-perspective

Mehta, N. & Pandit, A. 2018. Concurrence of Big Data Analytics and Healthcare: A Systematic
Review. International Journal of Medical Informatics, 114: 57-65.
National Association of Insurance Commissioners. 2019. Regulatory Review of Predictive
Models. Retrieved from:
https://naic.org/documents/comte_c_catf_predictive_model_white_paper_190510_clean.docx

National Institute of Standards and Technology (NIST). 2016. Networks of 'Things. Retrieved
from: http://dx.doi.org/10.6028/NIST.SP.800-183
NIST. 2011. The NIST Definition of Cloud Computing. Retrieved from:
https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication800-145.pdf

NIST. 2018. Blockchain Technology Overview. Retrieved from:
https://doi.org/10.6028/NIST.IR.8202.

NIST. 2019a. NIST Big Data Interoperability Framework. NIST Special Publication 1500-1r2.
Retrieved from: https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1500-1r2.pdf
NIST. 2019b. U.S. Leadership in A.I.: A Plan for Federal Engagement in Developing Technical
Standards and Related Tools. Retrieved from:
https://www.nist.gov/system/files/documents/2019/08/10/ai_standards_fedengagement_plan_9au
g2019.pdf.

NIST. 2019c. A Taxonomy and Terminology of Adversarial Machine Learning. Draft NISTIR
8269. Retrieved from: https://nvlpubs.nist.gov/nistpubs/ir/2019/NIST.IR.8269-draft.pdf.
Pasquale, F. & Ragone, T. A. 2017. Protecting Health Privacy in an Era of Big Data Processing
and Cloud Computing. Standford Technology Law Review, 17: 595-654.
Pearlman, A. 2019. HIPAA is the Tip of the Iceberg When It Comes to Privacy and Your
Medical Data. Retrieved from: https://blog.petrieflom.law.harvard.edu/2019/01/07/hipaa-is-the-tipof-the-iceberg-when-it-comes-to-privacy-and-your-medical-data/

Price, W. N. & Cohen, G. 2019. Privacy in the Age of Medical Big Data. Nature Medicine, 2:3743.
Raghupathi, W. & Raghupathi, V. 2014. Big Data Analytics in Healthcare: Promise and
Potential. Health Information Science and Systems, 2:3. Retrieved from:
http://www.hissjournal.com/content/2/1/3.

13

Shahbaz, M., Gao, C. & Hu, Y. 2019. Investigating the Adoption of Big Data Analytics in
Healthcare: the Moderating Role of Resistance to Change. Journal of Big Data, 6, 6.
Retrieved from: https://doi.org/10.1186/s40537-019-0217-y.
Wang, Y. & Hajli, N. 2017. Exploring the Path to Big Data Analytics Success in Healthcare.
Journal of Business Research, 70: 287-299.
Wang, Y., Kung, L., Wang, Y. C. & Cegielski, C. G. 2018. An Integrated Big Data AnalyticsEnabled Transformation Model: Application to Health Care. Information & Management,
55(1): 64-79.
National Research Council Institute of Medicine. 2013. U.S. Health in International Perspective:
Shorter Lives, Poorer Health, Woolf S.H., & Aron L. (Eds). Washington, DC: National
Academies Press. Retrieved from:
https://www.ncbi.nlm.nih.gov/books/NBK154484/

14

